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Sphingosylphosphorylcholine (lysosphingOlnyelin or 
SPC) is an effective and broad spectrutn cell growth 
promoting agent and a candidate for evaluation on 
wound healing. The effect of SPC on full-thickness 
excision and incision wounds in genetically healing-
impaired diabetic (d"'db) tnice was evaluated by tnea-
surement of wound area, skin strength, and tissue 
histology. The effect on cell proliferation was mea-
sured ill vivo by incorporation ofbromo-deoxyuridine 
and ill vitro by [3H]thymidine incorporation. SPC 
increased the rate of wound closure, with a statisti-
cally significant improvement in measured wound 
areas (p < 0.02, cotnpared with vehicle controls). The 
optimum concentration was 2-3 /A-M. SPC, alone arid 
in combination with msulin, stitnulated DNA synthe-
sis in cells known to participate in wound healing, 
including tnicrovascular endothelial cells. 111 vivo, 
T he sphingolipid m etabo lites, sphingosinc, sphin-gosine-1-phosphatc, and sphin gosylphosphorylcho-linc (SPC o r Iysosphingo myelin) , are emcrging as a n e w class of intra cellular second m cssen gers with a wide spectrum of activity in cell growth regu lation 
and signal transduction [1-5] . Of them. SPC is the most powe rful 
stimulator for cell proliferation. SPC is structurally re lated to 
sphingosin e-l-phosphatc, but contain s a c ho line moi ty conjugate d 
to the phosphate group . Despite shared struc tura l features, the 
actiOli of SPC is unlike that of its congeners . SPC induced an 
in crease in re lease of arachidonic acid and may act v ia both protein 
kinase C-d e pe nde nt and inde pc ndent sign a lin g pathways [6- 8], 
indicating a n ovel m echan.i sm of mitogenic stimulation. It was 
proposed that thc mitogcni c effec t ofSPC is du c in part to its abi li ty 
to m obilize calcium from inte rna l stores inde pende ntly of inositol 
triph osp hate (InsP 3) form ation [6,9] . R ecently, a n ovel intrace llular 
SPC-gated calcium channe l was detected in rat basophilic le uke mia 
cell s [10] . Several intrace llular sig naling pathways havc been iden-
tified as potential m e diato rs of SPC ac tio n. Thcsc include potent 
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Abbrevia tions: SPC, sphingosy lphosphorylcholine; PAEC. endothelial 
ce lls from porcine aorta ; PC MVEC , porcine cerebral microvesscl endothe-
lial ce ll s; R VTE. retrovirus transformed porcine cerebral microvcsse l 
endotheUal ce ll. 
SPC stimulated proliferation of keratinocytes, fibro-
blasts, endothelial cells, and cells around sebaceous 
glands and hair follicles at day 2-4 postwound, re-
sulting in a cotnplete re-epithelialization and pro-
found granulation tissue formation in excisional and 
incisional wound sites of db/db and db/+ tnice. Quan-
titative assessment of wound tissue section morphol-
ogy indicated that SPC induced up to a 3-fold in-
crease in the numbers of tnitotic cells, resulted in a 
smaller cross-sectional scar area, and led to more 
normalized tissue in the wound sites. SPC had no 
deleterious effect on wound skin strength. In conclu-
sion, the acceleration of dermal wound healing in 
animal models suggests that SPC could be an inter-
esting candidate for clinical application. Key 1II00,ds: 
lysospl'ill g01llyelill/ spl'illgosille/ sphillgo I ip id/ cell P"o lifel'a-
tiou. ] Illvest Del'lllatoi 106:232-237, 1996 
calcium m o biliz ing activity and stimulation of arachidonic acid 
re lease [6,10 -11]. The mitogeni c action ofSPC was a lso synergistic 
with peptide mi togens [6 ,12]. 
Little is known about whether SPC is active in tissuc repair. 
Wound hea liJlg is a complex localize d biological process that 
involvcs ccll proliferation, ce ll recruitme nt, and t issue remo deling 
[1 3-14]. T he stimulation , by SPC, of prolife ration of cell s impor-
tant in the wound healing process led lIS to the h ypothesis that 
exogenous SPC may accc le ra te wound hea lin g. 1n this study, we 
exam.ined th c efFect of SPC on the rate of excision wound closure, 
on inc ision wou nd histology, on wound ccll prolife ration ;11 ";1/0, 
and on ;11 ,,;11'0 proliferatio n of microvascular and large vessel 
e ndothclial ce ll s. SPC appears to have pote ntial the rape utic li se in 
the improvem ent of wound healing. 
MATEIU ALS AND METH ODS 
Materials Sphingosylphosphorylcholine. obta ined from Sigma Chemical 
Co. (St. Louis. MO). was analyzed to be greater than 95'!/" pu.rity by 
th.in-Iayer chromatograph y. SPC was prepared by acid hydrol ys is of bovine 
brain sphingomyelin , a procedure that has been reported to yield a 72:2 
D-cITlhro / L-lhrco mixture [1 5] with mitogenk properties iden tica l to syn-
the tic 2S, 3R. 4E (D-cr)'fhro) SPC [16]. Insulin , transferrin , and the cell 
culture media Du lbecco' s modified Eagle's medium. M199, and Way-
mouth 's wen! from Gibco-BH .. L (Gaithersburg, MD) . NIH /3T3 and B ALBI 
3T3 fibrobla st cells were obtajned from the American Type Culture 
Collection (ATCC. R.ockville, MD) . Porcine aorta endothelial cell s (PAEC) 
[J 7). porcine cerebral microvessel endothelial ce lls (PCMVEC) [1 8), and 
Tetro-v irus tra ll sfo rln cd po rc ine cerebral 1l1ic rovcsscl endothelial cells 
(R VTE) ['J 9] wcre isolated and maintained as described. 5-BroI110-2 ' -
0022-202X /96/S10.50 • Copyright 1996 by The Society for Investiga tive Dermatology. Inc. 
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deoxyuridine (BrdU) was purchased from Sigma . Geneticall y hea ling 
impaired diabetic mice (db / dh), and their normal Ii ttermates (d/)/ + ), 011 a 
C57BL/ Ks] phenotypic background. were from Jackson Laboratories (Bar 
Harbor, ME). 
Cell Proliferation Assay ill VIIJ'O Cells at 60 - 80% of confluence were 
seeded at a density of 5 X 10J ce lls/well into Falcon 96-well plates in 
Du.lbecco's modified Eagle's medium (foo: NIH/3T3 and BALB/3T3) and in 
M199 (for PAEC , PCMVEC, and RVTE) . T he media wcre supplemented 
with 10% fetal bovine serum, penicilUn ('100 uni t./ I11I), and streptomycin 
(100 J-Lg/ ml). O n the day of the experiment. the medium was changed to 
Dulbecco's modified Eagle's medium / Waymouth 's ('I :1) containing bovine 
serum albumin (20 J-Lg/ml) , transferrin (5 J-Lg/ml) , and insulin (2 J-Lg/ml) . 
The ce lls were exposed to the absence o r presence of SPC (10 J-LM) fo r 24 
h and then incubated with 0 .4 J-LCi of[3H]thymidine for another 20 h . T he 
fol d stimulation of incorpo ration of [' H] into trichloroacetic acid-insoluble 
ma terial was calculated relative to contro ls. Values arc the means of 
triplica te determinations. Standard deviations were routinely less than 10% 
of the mean. 
Cell Proliferation Assay ill Villi' BrdU (an analog of thymidine) 
labeling and immunostaining, a sensitive teclmiquc to identify cells in 
S-phase [20-24 ], was used to assess cell proliferation in wound tissue. 
Sixty-four mice (32 db/ + and 32 db/db Inice) aged 8 -11 wk o ld were 
divided into four equal groups: SPC- treated or phosph:lte-bu(fered sa line 
(PBS, as control)-treated excisional and incisional groups. In the exc isional 
wound groups, a sin gle full-thi ckness 6-111111 diameter (0.28 cm 2) excisional 
wound was made on the mid-dorsum with a sterile biopsy punch and 
received 10 J-Ll/dose of 2 J-LM SPC (0 .02 nM) in PDS once dal ly. In the 
incisional wound groups, a full-thi ckness incision about 2 cm in length was 
made as previously described [25-26] and received 15 ILl/dose of2 J-LM SPC 
(0 .03 nM) in PBS (5 J-LI to pically to wound margin and 10 J-LI subcutaneously 
injected to the wound base) once dail y. T he corresponding controls 
received PBS only and were processed identically. To prevent disturbance 
of wounds by Jjcking, animals were individua lly hOllsed after creation of 
wounds. T he SPC- or PBS-treated wounds in both excisional and incisional 
groups were harvested fro m 2 db/+ mice on each day 2, 3, 4, or 6 after 
wounding. Similarly . wounds were harvested from four, two, and two db / db 
mice at day 4, 6, and 7 after wounding, respectively. Each animal received 
a single intravenous injection of l3rdU at a dosage of 50 mg/ kg body weight 
2 h befo re death. 
W ound Area Measurement A single full -thickness 6-mm diameter 
excisional wound was made with a steril e biopsy punch on the mid-do rsum 
of each db / db mouse and le ft undressed. In each experiment, groups of five 
mice were treated with one of the several concentrations of SPC in PBS. o r 
PBS vehicle (as control). Mouse wounds were treated with l OlLI/ dose of 
either SPC or PBS applied topically once daily for 15 consecuti ve days after 
injury. Scabs were gentl y removed on day 4. 6. 8, '10 , 12, 14, and 16 
pos tinjury to accura tel y visuali ze the wound margin and to faci litate SPC 
access to tlle wound. T he wounds and a centimeter scale were photo-
graphed at 1 h after wounding (day 0) and alternate da ys thereafter. Each 
photograph Was processed to amp li fy the wound area to 50 -100 times the 
original. Im:lge analysis software supplied w ith the Dio-Rad MRC 500 
confocal system (Bio-Rad Laboratories, Microscicnce Ltd .. Hemel Hemp-
stead, UK) was used for the measurement of the amplified wound areas. 
Mean (~ SD) wound areas were expressed as percent of initial wound area 
(at day 0). 
Breaking Strength Measurement Li nea r incisions abo ut 2 cm in length 
were made on the dorsal aspect of the db / db mice as desc ribed above. 
Thirteen mice (total of three experiments) each received 15 J-LI of2 J-LM SPC 
in PBS once daily for 12 days (5 J-LI topical on incision margins :md 10 J-LI sc 
at the base of the incision) . The mice were sacrificed at da y 17 (8 mice) or 
2 7 (5 mice) postinjury. The control wounds in another group of 13 mice 
received PBS only and were processed identica lly. T he wound strip was 
excised from the dorsal skin and cut in to an 8-mm wide strip using a 
tenlplate . Breaking strength was Tncasurcd inl lTIcdiatcly after excisio n llsing 
a custom-made tensiometer. Tension was applied at a constant ratc of 
1 cm/min using a 1.0-kg force transducer. Statistical signi ficance of 
responses were evaluated using one-way analysis of varian ce. 
T issue P r ocessing and Quantitative Assessment To visualize UrdU 
incorporation and neoangiogenesis. ill1munostaining was performed 0 11 
5-ILm thick tissue sections using monoclonal antibodies against BrdU 
(Sigma) or factor V11I-related antigen (Zymed Laboratories, Inc. , South San 
Francisco, CA) according to the procedures provided by the manuf.1cturer. 
Skin samples harvested from incision wounds at day 17 after wounding were 
fixed in 10% formalin, embedded in paraffin, and stained w ith Masson 
trichrome . Quantitative evaluation of the Spc effect on wound healing was 
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F ig ure L SPC stimula tes the rate o f healing of excisional wounds 
in diabetic mice, D, the PBS contro l; 1m, 10 J-LM SPC; IrIlI. 5 J-LM SPC; ., 
2.5 J-LM SPC. Error [,nrs, SO. * Statisti ca l significance at the p < 0.05 leve l 
(one-way ana lysis of variance). 
performed at an objective lens magnifica tion of 4 X o r lO X with a Nikon 
Optiphot microscope interfaced via a color camera to an inlage analysis 
sys tem (BioScan Inc., Edmonds, W A). The number ofBrdU-labeled cells, 
the cross-sectional scar area, and the thickness of dermal and adipose laye.rs 
were measured in wound sites. Values are the means ( :':SD) of two to three 
slides fro m each animal in the groups. 
RESULTS 
SPC Improves Wound Healing E xcision wounds in db/db 
mice were treated w ith con centrations ofSPC from 0.5 to 100 J-LM 
for measureme nt of wound area. Initial experiments establish e d 
that a wide ran ge of concentrations (0 .5-50 J.LM) were apparently 
b enefic ial and tha t the optimum con centration was 2- 3 J-LM . 
Measure m e nt of the wound areas demonstra ted that wounds 
treated with concentrations of SPC from 2 .5 to 10 J.LM b ecam e 
sm aller th an control wounds and th e improvem ent in h ealing 
b ecam e statistically significa n t (p < 0 .05) by day 10 in the h ealing 
process (Fig 1). W h en the e ffect of 3 J.LM SPC was compared in aU 
experime nts (Table I), a steady and statistically sig nifi cant (p < 
0.02) improvem ent was found, until th e h ealing in the experim e ntal 
group was essentially complete. T h ese fu.U- thickness lesions in mice 
may stimulate deep dermal d ecu b itus and diabetic u lcers in human s. 
Su ch wounds fi'equent1y p enetrate throug h the dermis and are often 
Table I. Time Course of Effects of SPC on Wound Areas" 
Day After Wounding 
6 
8 
10 
12 
14 
16 
Area (% control" ~ SEMI 
97 ~ 8 
88 ~ 4' 
57 ~ 9f 
35 ~ 12,< 
31 :t 11-< 
63 ~ 40" 
n o'/ 
15 
15 
15 
15 
10 
10 
" Wound arcas were m easured in db / db m o use excisio n wounds treated with 3 IJ-M 
SPC or with PBS (control). 
/. T he menu s of the :lrcas of SPC-trcatcd wound!! were expressed a!i a percentage of 
the areas of control wounds. T h e areas of the contro l (PBS-treated wounds were 27.4 
1ll1ll2 :t 4 .1 at d ay 6. 23 .4 1II1ll2 :t 5.3 at day 8 , 18.5 111",2:t 4.3 at day 10. 17.01111112 
:t 4.0 at day 12. 4.9 111111' :t 3. 1 at day 14, a"d 5.3 111111 ' :t 2 .2 at day 16 . The 
percentages of control values were compared w ith the va.luc at day 6 by an unpaired 
two-tailed t tcst. 
r Standard e rro r of the menns of lhe determinations. 
,/ T he number ofmkc treated with SPC or PBS. E01Ch control or cxpcri mcncal group 
consisted of five an imals per experime nt. 
C Non-significant changes. 
I I' < 0.05. 
.< I' < 0.U2 . 
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Figure 2. SPC improves incisional wound histology. n) SPC-treated (0.03 nmoles once daily for 12 days) wound harvested at day 17 after wounding. 
I) Control. The incision wound is marked with arrows. Scnle bar, 200 IJ.1n . 
debrided to remove necrotic tissue prior to treatment, thereby 
generating a deep wound bed similar, bllt I/.ot iriClltica l, to that 
produced by punch biopsy in rodents. T he effect of SPC on wound 
strength was evaluated by application of SPC to incisional wounds 
in db/dlJ mice . 
Histological examination of SPC-treated wounds at day 17 after 
wounding revealed minimal scar contracture, a more norma] 
complement of fat cells in the dermal layer and the subcutaneous 
layer (Fig 2a), and no scar band as seen in the control (Fig 2b). 
Quantitative analysis of the quality of healing was determined by 
measuring cross- sectional scar area, the thickness of the dermis , and 
the thickness of the adipocyte layer. SPC treatment led to signifi-
cantly smaller scar area and more normal adipocyte layer (Table 
II), compared with corresponding controls, indicating an improve-
ment of wound quality by the application of SPC. In three 
experiments, SPC produced a consistent, but not significant, in-
crease in skin breaking strength, 24% above controls at day 17 after 
wounding, and 15'1'0 above con trols at day 27 after wounding (p 
0.065) . 
Table II. SPC Improves Wound Remodeling" 
SPC 
PUS 
Scar Area 
(IJ.m2 ) 
404,000 :':: 238 ,000/' 
976,000 :':: 315,000 
Thickness of 
Dermis (IJ.m) 
412 :':: 294 
1,672 :':: 167 
T hickness of 
Adipose (p.m) 
194 :':: 16/' 
o 
, I The cross-sectio nal scar Mea •• lnd the thickness of dermis and adipose layers were 
cva lu;ltcd in incisiollil l wounds in db/db mice treated with SPC (2 J.l.M) or PBS once 
dai ly fo r 12 days and harvested at day 17 after wound ing. Values arc mean :t SO of two 
to thrce slides of cHeh wou nd of the gro ups (11 = 8 in each group). 
" p < 0.05. compared with controls. 
SPC Improved Early Wound Histology and Increased ill 
Vivo Cell Proliferation In order to evaluate the effect of SPC 
earlier in the healing process , the cell proliferation ill "ivo was 
evaluated in tissue sections. SPC induced an early and profound 
keratinocyte proliferation, and migration of epidermis to the margin 
of excisional and incisiona! wounds in both db/rib and db/ + strains 
of mice, while tissue repair in PBS-treated controls was much 
slower (Fig 3a-j). The SPC-treated incisional wounds of db/db 
mice were completely re-epithelialized at day 4 after wounding, 
and a large amount of granulation tissue filled the wound sites (Fig 
3a). T here was a high density of BrdU labeled cells (Fig 3a) , 
whereas the contro ls had fewer BrdU-Iabeled cell s and a less 
organized wound tissue (Fig 3&). At higher magnification, it was 
clear that SPC stimulated prolife ration of cells in the wound 
margin, cells (presumably keratinocytes) at the dermal-epidermal 
junction, indi vidual cells in the dermis (possibly fibroblasts), and 
cells in the dermis located in sebaceous glands and the outer root 
sheath of hair follicles (Fig 3c). T he tissue response to SPC stimulus 
in the db/ + mice was similar, but much earlier (day 2), than that in 
db/db mice (Fig 3d-e). Similar results were also seen in the 
SPC-treated excisional wounds (Fig 3j). The effects of SPC on ill 
"ivo cell proliferation were quantified by image analysis. SPC led to 
statistically significant increases (p < 0.01) in numbers of mitotic 
cells, up to a 3-fold increase (Table III) . In SPC-treated wounds, 
many endothelial cells in the walls of neo-capillaries were labeled 
with BrdU and could be distinguished by their flat cross-section 
(Fig 3g). T he intensive staining of factor VIIl-related antigen, and 
the increase in the number of neo-capillaries, demonstrated that 
SPC was ,I potent stimulator for endothelial cell proliferation and 
neoangiogenesis (Fig 3/1). 
SPC Stimulates Cell Proliferation ill Vitro For comparison, 
the effect of SPC was also evaluated on the growth of several types 
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Figure 3. SPC stimulates cell proliferation ,'" l1ivo. a) BrdU-labc.lcd cells (fIIltJII4wads) in an SPC-treated (0.03 nUloles once daily) incisional wound in a diabetic 
mouse at day 4 after wounding. I,) PBS-treated incisional wound (control of Panel a). c) High magnification of Pallel a. d) SPC-treatcd (0.03 nmoles Once daily) 
incisional wound in a db/ + mouse at day 2 after wounding. e) PBS-treated wound. control of Pallelll . ./) SPC-treated (0.02 nmoles once daily) excisional wound 
in a db/+ mouse at day 3 after wounding . • ~) DrdU-Iabeled S-phase endothelial cells around the walls of nco-capillaries in an SPC treated excisional wound ofa db/db 
mouse at day 6 after wounding. II) profound neoangiogcnesis (staining off.~ctor VlH- rc1atcd antigen. f111'01IJ1Ieads) at day 6 after wounding in an SPC-treated incisiona] 
wound of a dl,/ + mouse. E, D, A, S, and W, the locations of the epidermis. dennis, adipose layer, sebaceous gland, and wound margin, respectively. Srale bar:<: a, 
b, d, e) 400 I.un; J,I,) 200 J.Lm; e,g) tOO J.L1ll. Representative of two to three sections from each of two to four mice per treatment group at each time. 
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Table III. Effect of SPC on Cell Proliferation in Vivo fl 
dl,/ + Mice db/dl, Mice 
Days 2-3" Days 4-6 Day 4 Days 6-7 
SPC 117 :!: 44 ' 119 :!: 33' 120 :!: 42' 124 :!: 52'· 
PBS 60 :!: 29 39 :!: 26 83 :!: 35 52 :!: 51 
Fold illcrease 2.0 3.0 1.4 2.4 
" The wOllllds in di"betic mice (dbld{,) ""d their normal littermatcs (db/+) received 
SPC (2 J.LM in PBS). o r PBS. and were harvested at the day after woullding as 
in dicated. The numbers of ce lls labeled with BrdU in the wound site were counted 
using a l OX ohjective lens (resulting in an area of 0.9861 111m2 displayed on the screen) 
with an image analysis system as described in Allnteritlls n"d J\I/cr/wds. The values arc 
means ~ SO of two fields ea ch of two to three slides from each wound. The time 
periods were grouped so that each period (e.g., day 2-3) contained four mice. 
/, Days nftcr wOllnding. 
r p < 0.01, compared with corresponding contro ls . 
of cultured cells, includit-.g 3T3 fibrob lasts, primary endothelia l 
cells (PAEC, PCMVEC), and virally transformed endothelial cells 
(R VTE). SPC greatly stimulated DNA synthesis in all these cells 
(Table IV). Consistent with studies on other cells, including large 
vessel endothelial cells, SPC caused a concentration-dependent 
increase in [3H]thymidine incorporation into DNA, with a maxi-
mum effect at 10 /LM (data not shown). The stimu lation of 
endothelial cell proliferation supported the observation ;11 1/ ;110 (Fig 
3g) and was similar in magnitude to the aggregate cellular response 
;11 IJivo (compare Table III and Table IV). 
DISCUSSION 
Role ofSPC in Wound Healing The enhancement ofheaJing 
by SPC demonstrated modulation of an important physiological 
function by a member of a novel class of regulators: the sphingo-
lipids. The dose-response of SPC in promoting excision wound 
closure indicated tllat not only was SPC efficacious but also that 
optimal efficacy was achieved with 2-3 /LM, a level consistent with 
the ;11 II;fI'O dose response for growth of fibroblasts and endothelial 
cells (0 .01-20 /LM). Our results showed that SPC appeared to 
enhance wound closure over a wide range of concentrations 
(0.5-50 /LM). The small but consistent increase of breaking 
strength in three mouse incision wound expel·iments was also 
observed within this dose range. 
The ellect of SPC on wound area was statistically sign ifi cant. 
Importantly, SPC did not increase wound dehiscence. Agents that 
improve the rate of closure at the expense of wound strength are of 
little clinical value. For example, basic fibroblast growth f.,ctor 
applied to healing collateral ligaments improved angiogenesis, but 
decreased ligament tensile strength [27] . SPC, on the other hand, 
increased the rate of wound closure with no deleterious effect on 
skin strength. The more normalized tissue in dermis and subcuta-
neous layers in the incision site may contribute to the iJ1CreaSe of 
breaking strengtb, compared with the scar tissue in controls. SPC 
stimulated profound granulation tissue formation , angiogenesis, 
and epithelial proliferation early in the wound healin g process, and 
greatly decreased scar tissue amount and increased the adipose 
Table IV. Effect of SPC on Different Cell Types ill Vitl'O" 
Cell Types 
BALB/ 3T3 
NII-I/3T3 
PAEC 
PC MVEC 
R.VTE 
Fold Change in 
DNA Synthesis" 
6.53 
5.12 
2.06 
2.42 
2.24 
"Cells cultured for 7 d were exposed to SPC <10 /-LM) for 24 h, alld [' Hjth)'l11idillc 
incorporation determined as described in !vlalerials alltl !vIet/lOlls . 
"The fold stimulation was calculated relative to control s. 
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component at a late stage of healing, suggesting e ffects of SPC on 
both acceleration of tissue repair and of tissue remodeling. 
Sphingolipids have been indirectly implicated in wound healing 
or disturbances of healing. In pediatric patients with Gaucher's 
disease, one of the sphingoHpidoses, bone fracture healing is 
impaired [28] and characterized by erosion of the bone, osteone-
crosis in th e area of the fracture, and disuse osteoporosis. Acute 
disturbance of sphingolipid metabolism by the bite of the bro\\~l 
recluse spider, Lox osceles I'edt/sa, often leads to persistent, healing-
impaired sores in humaJls [29] . Sphingomyelinase D, which de-
grades sphingomyelin to ceramide-1-phosphate, is the active agent 
in the venom. In addition, the level of sphingomyelins is altered in 
tissue after laser surgery [30]. 
Cellular Basis of SPC Action Although the statisticaIJ y signif-
icant improvement in wound area occurred la te in the healing 
process, a key event was the stimul ation of cell proliferation in the 
wound early in the healing process. SPC stimulated a wide variery 
of skin cell types ;11 II;VO. The proliferation of keratinocytes at the 
dermal epidermal junction, epithelial cell s associated with seba-
ceous glands and hair follicles, vascular endothelia l cells, fIbroblasts 
i.n the dermis, and perhaps some other cells, were stimulated. This 
observation validates the extensive ;'1 11;11'0 studies that report 
stimu lation of proHferation of cell lines from a variety of origins 
[6,10]. The cell proliferation observed in response to SPC is similar 
to the cell activation that occurs during normal healing, except that 
the stimu lation is earlier and more profound. 
T he action of SPC may be direct on many cell types, or mediated 
by one or a limited class of cells. The profound fibroblast prolifer-
ation in wound tissue may be directly stimulated by SPC (as the ill 
llilro experiments suggest) , or indirectly induced through an inter-
action m echanism between endothelial ceUs and fibroblasts, the 
SPC-mediated release of regulatory factors £i·om endotheHal or 
other cells, or the increased neovascularization. The SPC-enhanced 
endothe lia l cell proliferation and angiogenesis in the early phase of 
healing m ay provide additional histological cvidence to explain the 
effect of SPC on wound healing observed in this study. The large 
number ofkeratinocytes in rep licating phase labeled with BrdU and 
located in basalmcmbrane of epidermis demonstrated that SPC is a 
potent stimu lus for keratinocytes. This find ing also indicated that 
the improved wound closure induced by SPC treatment may result 
from an acceleration of re-epithelization by proliferation of kerati-
nocytes in the wound edge, instead of wound contraction. In 
SPC-treated wounds, there were many BrdU-Iabeled cell s located 
around the outer layer of se baceous glands and outer root sheath of 
hair follicl es. The proliferation of these epithel ial cells may contrib-
ute to the accelerated wound closure and remodeling and may aho 
improve the quality of the wound remodeling in the presence of 
SPC. The proliferative response of these skin cells ;11 11;11'0 and ;III' ;VO 
may explain, at least in part, the acceleration of wou nd closure rate 
and the improvement of breaking strength effected by Spc. 
In summary, SPC not only stimulated proliferation and DNA 
synthesis of skin cells ;11 IJilm and ;11 llill(), but also improved the 
fu ll-thickness excisiona l and incisional wound healing in heaJing-
impaired diabetic mice and the ir normal littermates . Future studies 
evaluating the ellect of SPC on wound healing in different species 
and in combination with peptide growth f.,ctors would be of great 
importance in view of its potential therapeutic use in tissue repair 
and wound healing. 
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